检索

Laparoscopic pelvic exenteration for malignant tumors of the female reproductive system: a case series

Lyadov V., Nevrov A., Garipov M., Moskalenko A., Simbiryov T., Galkin V.

(Rus)

卷 16, 编号 3 (2014)

Avastin in clinical chemotherapy of malignant tumors

Gorbunova V.

Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review

Sultanbaev A., Kolyadina I., Gilyazova I., Nasretdinov A., Musin S., Sultanbaeva N., Menshikov K.

(Rus)

卷 21, 编号 1 (2019)

HPV-associated lesions in the Russian Federation: assessment of the problem

Briko N., Lopukhov P., Kaprin A., Novikova E., Trushina O., Khaldin A., Isaeva D., Skvortsova A.

(Rus)

卷 17, 编号 1 (2015)

A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian

Poddubnaya I., Kolyadina I., Kalashnikov N., Borisov D., Makarova M.

Solitary metastasis of colorectal cancer in the left adrenal gland 4 years after surgery on the primary tumor. Case report

Budurova M., Trifanov V., Kopylov V., Kuznetsova O., Chernichenko M., Poluektov S.

(Rus)

Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

Supportive therapy for ovarian cancer

Pokataev I., Tyulyandin S.

(Rus)

Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review

Stanoevich I., Ioutsi V., Lysovolenko N., Alekseev I., Kondrashkina A., Polianskii M., Pis'mennaia E.

(Rus)

Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region

Zhuikova L., Ananina O., Sirotina A., Pikalova L., Fokin V., Kononova G.

(Rus)

Complex radiologic imaging of early breast cancer (literature review)

Aliyeva G., Korzhenkova G., Kolyadina I.

(Rus)

卷 17, 编号 1 (2015)

Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)

Kolyadina I., Poddubnaya I., Van de Velde C., Kuppen P., Frank G., Komov D., Karseladze A., Bastiaannet E., Dekker-Ensink N.

Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer

Zhurman V.

(Rus)

卷 21, 编号 2 (2019)

Lung cancer in the Tomsk region (epidemiological aspects)

Choynzonov E., Zhuikova L., Ananina O., Odintsova I., Pikalova L.

(Rus)

Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary

Kutumova O., Kononova L., Dobretsova E., Shulmin A., Korotkova K., Rossiyeva T.

(Rus)

Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study

Sokolova T., Solov'eva T., Aleksakhina S., Janus G., Goryainova A., Gluzman M., Orlova R., Stukan A., Zukov R., Zyuzyukina A., Murunova Y., Sultanbaev A., Vorobeva E., Mikhaevich L., Pyliv V., Lysenko A., Khachmamuk Z., Kozlov A., Bakharev S., Parsyan S., Rossokha E., Osidze L., Shumskaya I., Agaeva A., Kasmynina T., Klimenko V., Akhmetgareeva K., Vakhitova A., Chakhkieva M., Dmitriev V., Bakshun Y., Vasilyev A., Gasimly D., Kravchenko N., Maksimov D., Nesterova A., Sharvashidze I., Gadzaova C., Rakhmankulova G., Khamgokov Z., Amirkhanova I., Bembeeva L., Vladimirov V., Petrenko O., Ruskova N., Serikova E., Subbotina K., Tkachenko S., Chang V., Erdniev S., Barbara V., Vasilevskaya A., Mikheeva Y., Popova N., Startseva E., Fateeva A., Yukalchuk D., Grechkina A., Musaeva K., Odintsova S., Stel'makh A., Khabibulaeva P., Khlobystina A., Shvaiko K., Basova E., Bogomolova I., Bolieva M., Goldberg V., Kibisheva M., Menshikov K., Ryazanov D., Stepanova M., Udalova Y., Shkradyuk A., Chapko Y., Shchukina A., Khabriev I., Kirtbaya D., Degtyarev A., Epkhiev A., Tyugina Y., Murachuev M., Togo A., Ievleva A., Imyanitov E.

(Rus)

(Eng)

PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary)

Uvarova K.

(Rus)

卷 17, 编号 4 (2015)

The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)

Vaschenko L., Dashkova I., Kechedzhieva E., Babieva S.

Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report

Semenov E., Gasymly D., Zyuzyukina A., Zukov R.

(Rus)

Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo

Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.

(Rus)

Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

Effect of internal subtype on the efficacy of CDK4/6 inhibitor therapy in advanced HR+/HER2breast cancer: A review

Grechukhina K., Filonenko D., Sukhova M., Zhukova L.

(Rus)

Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study

Zhukova L., Bolotina L., Dvornichenko V., Fadeeva N., Ganshina I., Grechukhina K., Hasanova A., Kislov N., Kudryavtsev I., Manikhas A., Musaeva N., Nizhegorodtseva A., Sadikova O., Sakaeva D., Snegovoy A., Stroyakovskiy D., Tjulandin S., Trishkina E., Vladimirova L., Volkov N., Kostalanova Y.

(Rus)

Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study

Evdokimov V., Bloshchinenko A., Abolmasov A., Vilensky A., Laskov M.

(Rus)

Cabozantinib in the treatment of patients with advanced renal cell carcinoma

Volkova M., Turupaev K., Kalinin S.

(Rus)

卷 22, 编号 1 (2020)

Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer

Kolyadina I., Danzanova T., Khokhlova S., Trofimova O., Kovaleva E., Rodionov V., Poddubnaya I.

(Rus)

The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer

Kolyadina I., Poddubnaya I.

(Rus)

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

Yudin D., Laktionov K., Laktionova L., Breder V.

(Rus)

Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS)

Lienhard D.

(Rus)

Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer

Musaeva Z., Chekalova M., Mesheryakov A.

卷 20, 编号 2 (2018)

The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan

Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.

(Rus)

卷 19, 编号 1 (2017)

Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers

Stilidi I., Kotyukova A., Lyadov V.

(Rus)

卷 18, 编号 1 (2016)

Rare morphological forms of breast cancer: features of surgical approach

Vysotskaya I., Letyagin V., Kolyadina I., Martynova G.

(Rus)

Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study

Volkova M., Kalpinskiy A., Goncharova O., Menshikov K., Karabina E., Dergunov A., Polshina N., Alexandrova E., Lebedinets A., Panov A., Sultanbaev A., Usynin E., Volkonskiy M., Mikhalyuk V., Zukov R., Anzhiganova Y., Gusniev M., Igumnova E., Kuzmicheva S., Pokataev I., Olshanskaya A., Pervakova N., Parsadanova E., Sannikova T., Bystrov A., Dubovichenko D., Miliausha M., Chubenko V., Shkret K., Gorshenina M., Davlatova M., Kosareva A., Lutoshkina O., Maslova O., Makhnutina M., Mishina A., Murzalina M., Podyacheva O., Kalinin S., Mailyan O., Safarova A., Semenova K., Strokova M., Urashkina E., Shmygina O.

(Rus)

Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study

Zabotina T., Chertkova A., Borunova A., Kushlinskii N., Gershtein E., Zakharova E., Shoua E., Tsiklauri V., Samoylenko I., Khoroshilov M., Kadagidze Z.

(Rus)

Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series

Shevchuk A., Krylov A., Knyazev R., Afanasieva K.

(Rus)

Which faecal blood test is more accurate in detecting bowel cancer and large polyps in population screening? (Russian Translation of Cochrane Plain Language Summary (PLS))

Plyakhina K.

(Rus)

Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS)

Ziganshin A.

(Rus)

The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer

Gordeeva O., Kolyadina I., Zhukova L., Gan'shina I., Komov D., Meshcheriakov A.

(Rus)

卷 15, 编号 1 (2013)

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case

Magamedova O., Oganesyan L., Feoktistova P., Feidorov I.

(Rus)

Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials

Tcherkassova J., Prostyakova A., Tsurkan S., Suganov N., Boroda A., Zhilenkova A., Pirogova J., Sangadzhieva Z., Rusanov A., Rozhkov A., Fatyanova A., Nikitina N., Bagmet N., Sekacheva M.

(Rus)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer

Ognerubov N.

(Rus)

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS)

Alexandrova E.

(Rus)

卷 21, 编号 1 (2019)

The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)

Morozov D., Kolyadina I., Poddubnaya I., Chumakov P., Ilinskaya G., Bokhian V., Sopova M.

(Rus)

Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

Editorial B.

(Rus)

Isolated metastasis to the scalp in occult breast cancer: a clinical case

Ognerubov N., Sergeev R., Hizhnyak A., Ognerubova M., Dzhabrailov M.

(Rus)

Place of durvalumab in the treatment of biliary tract cancer: A review

Breder V., Ledin E., Chubenko V., Orlova R., Petkau V., Pokataev I.

(Rus)

Breast cancer: genetic personal risk factors: A review

Zolotykh M., Bilyalov A., Nesterova A., Gimranov A., Filina J., Rizvanov A., Miftakhova R.

(Rus)

Malignant neoplasm of the bronchi and lung: Russian clinical guidelines

Laktionov K., Artamonova E., Borisova T., Breder V., Bychkov I., Vladimirova L., Volkov N., Ergnian S., Zhabina A., Kononets P., Kuzminov A., Levchenko E., Malikhova O., Marinov D., Miller S., Moiseenko F., Mochal’nikova V., Novikov S., Pikin O., Reutova E., Rodionov E., Sakaeva D., Sarantseva K., Semenova A., Smolin A., Sotnikov V., Tuzikov S., Turkin I., Tyurin I., Chkhikvadze V., Kolbanov K., Chernykh M., Chernichenko A., Fedenko A., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil’mutdinova I., Gridneva I., Eremushkin M., Zernova M., Kasparov B., Kovlen D., Kondrat’eva K., Konchugova T., Korotkova S., Krutov A., Obukhova O., Ponomarenko G., Semiglazova T., Stepanova A., Khulamkhanova M.

(Rus)

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib

Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.

(Rus)

Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer

Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.

Clinical prognostic factors of bilateral synchronous renal cancer

Komarov M., Matveev V., Volkova M., Komarov I., Ridin V.

(Rus)

卷 19, 编号 1 (2017)

The role of bevacizumab in the treatment of patients with ovarian and cervical cancer

Khokhlova S.

(Rus)

Neuroendocrine tumors of the colon: an analysis of the literature and own experience

Kochatkov A., Bogomazova S., Negardinov A., Alimova Y., Lyadov V.

(Rus)

卷 16, 编号 1 (2014)

The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program

Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.

Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study

Golubenko E., Savelyeva M., Poddubnaya I., Korennaya V.

(Rus)

Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study

Sultanbaev A., Menshikov K., Musin S., Nasretdinov A., Fatikhova A., Izmailov A., Lipatov O., Ayupov R., Sultanbaeva N., Menshikova I., Serebrennikov G.

(Rus)

Second primary cancer in patients with head and neck squamous cell carcinoma: case report

Agabekyan G., Stelmakh D., Aydarbekova A.

(Rus)

Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data

Savchenko I., Stilidi I., Dzhanyan I., Antonova E., Polyakov A., Egorova A., Chulkova S., Breder V.

(Rus)

Benefits and limitations of breastfeeding for mothers with malignant tumors

Ladodo O., Iurova M., Khokhlova S., Rodionov V., Sheshko E., Zubkov V., Makieva M., Chutkova D., Akhapkina E., Degtyarev D.

(Rus)

Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer

Editorial B.

(Rus)

卷 19, 编号 1 (2017)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer

Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.

(Rus)

卷 17, 编号 4 (2015)

Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas

Borisov P., Orlova R., Shkolnik M., Karlov P.

卷 15, 编号 2 (2013)

Prognostic value of p53 expression in patients with stage I breast cancer

Kolyadina I., Poddubnaya I., Van de Velde C., Kuppen P., Liefers G., Dekker-Ensink N., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D., Karseladze A., Ermilova V., Vishnevskaya Y., Frank G., Banov S.

Clinical benefits of parenteral iron carboxymaltose in patients with colorectal cancer: a retrospective observational study

Postolov M., Suvorov V., Kravets A.

(Rus)

Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study

Sultanbaev A., Kolyadina I., Menshikov K., Musin S., Nasretdinov A., Sultanbaeva N., Rakhimov R., Lipatov D., Menshikova I., Izmailov A., Lipatova E.

(Rus)

Diagnostic potential of endosonography in primary and secondary esophageal tumors: retrospective study

Khalaev Z., Suleymanov E., Malikhova O., Tumanyan A., Krylovetskaia M., Kontsevaya A., Salimova A., Makarova M.

(Rus)

卷 19, 编号 2 (2017)

PARP inhibitors in female reproductive system cancers

Pokataev I., Tyulyandin S.

(Rus)

卷 25, 编号 4 (2023)

Results of pelvic exenteration in patients with cervical cancer: clinical experience

Khakimov G., Khakimova G.

(Rus)

The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study

Khatkov I., Semenov N., Izrailov R., Efanov M., Dalgatov K., Zhukova L.

(Rus)

Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis

Valiachmetova C., Siraev E., Izmailov A.

(Rus)

Classification of breast cancer subtypes based on RNA profiling and immunohistochemical methods: clinical and biological aspects: A review

Imyanitov E.

(Rus)

Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report

Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.

(Rus)

Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research

Kolomejtseva A., Bokova S.

(Rus)

The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

Shlivko I., Garanina O., Artamonova E., Ganshina I., Zhukova L., Koroleva I., Michenko A., Semiglazova T., Filonenko D.

(Rus)

Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer

Radzhabova Z., Kotov M., Girshovich M., Ponomareva O., Tkachenko E., Mitrofanov A., Radzhabova M., Levchenko E.

(Rus)

PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021

Board E.

(Rus)

Synchronous thyroid gland metastases from breast cancer. Case reports

Ognerubov N., Antipova T., Palkina E.

(Rus)

Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma

Ignatova A.

(Rus)

Breast cancer

Zhukova L., Andreeva I., Zavalishina L., Zakiriakhodzhaev A., Koroleva I., Nazarenko A., Paltuev R., Parokonnaia A., Petrovskii A., Portnoi S., Semiglazov V., Semiglazova T., Stenina M., Stepanova A., Trofimova O., Tyulyandin S., Frank G., Frolova M., Shatova I., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.

(Rus)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer

Ganshina I., Gordeeva O., Manukian M.

(Rus)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma

Bolotina L.

(Rus)

Opportunities for metastatic triple negative breast cancer therapy

Ganshina I., Gordeeva O., Manukyan M.

(Rus)

卷 21, 编号 2 (2019)

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience

Kolyadina I., Bulavina I., Petkau V., Strakhova N., Gorbunova V., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Gan'shina I., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Khokhlova S., Filonenko D., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Vladimirova L., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Orlov A., Kostalanova I., Levchenko N., Osipov M., Karandeeva T., Evstigneeva I., Chernov I., Kolokolov D., Povyshev A., Shatokhina A., Cherniakova E., Shkodenko O., Kuz'mina E.

(Rus)

卷 20, 编号 2 (2018)

The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)

Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.

(Rus)

卷 20, 编号 1 (2018)

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.

(Rus)

卷 19, 编号 3 (2017)

Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving

Artamonova E.

(Rus)

卷 19, 编号 2 (2017)

The treatment of patients with advanced lung cancer associated with EGFR mutation

Bolotina L.

(Rus)

Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene

Ryazhenov V., Gorokhova S.

(Rus)

Long-term treatment of neuroendocrine tumor of the pancreas

Khvastunov R., Egorov S., Kargin A., Kim A.

(Rus)

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia

Bolotina L., Manziuk L., Gorbunova V., Kovalenko E., Mukhametshina G., Khasanova A., Vladimirova L., Mitashok I., Prokofyeva E., Evstigneeva I., Andreyashkina I., Abramova N., Popova I., Karabina E., Teterich A., Gaysina E., Chubenko V., Limareva S., Tikhanovskaya N., Storozhakova A., Samaneva N., Svetitskaya Y., Snezhko T., Kalabanova E.

(Rus)

卷 18, 编号 1 (2016)

Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy

Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.

(Rus)

卷 17, 编号 3 (2015)

Adenosquamous carcinoma of the colon: case report

Nefedova N., Kharlova O., Malkov P., Kharlov N., Danilova N.

卷 17, 编号 4 (2015)

Modern possibilities of targeted therapy in metastatic colorectal cancer

Gorbunova V.

卷 16, 编号 4 (2014)

Surgical results in patients 75 years and older with gastric cancer

Rokhoev G., Stilidi I., Nered S.

卷 16, 编号 4 (2014)

The effect of combinated treatment of a metastatic HER2-positive stomach cancer

Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.

卷 16, 编号 2 (2014)

High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)

Seryakov A., Ovchinnikova L., Zabelin M., Yakubov T., Sidorov D., Ovchinnikov M.

卷 16, 编号 1 (2014)

The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer

Moskovskaya E., Novikova E., Korneeva I.

卷 15, 编号 4 (2013)

The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer

Cherkasova M., Khokhlova S., Limareva S., Bazaeva I., Orel N., Gorbunova V., Poddubnaya I.

卷 15, 编号 1 (2013)

Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results

Garbuzov M.

Mammography followed by ultrasonography compared to mammography alone for breast cancer screening in women at average risk of breast cancer (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

Editorial B.

(Rus)

卷 25, 编号 4 (2023)

How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review

Zhukova L., Bordin D., Dubtsova E., Ilin M., Kiriukova M., Feoktistova P., Egorov V.

(Rus)

Relationship of the integrin profile of the primary tumor to metastasis to regional lymph nodes in breast cancer

Zavyalova M., Kuznecov G., Grigoryeva E., Tashireva L., Pismenny D., Perelmuter V.

(Rus)

Remote multimodal prehabilitation in the presence of cachexia and resectable gastric cancer: a clinical case

Lyadov V., Boldyreva T., Achkasov E., Gorshkov A., Chashchin M., Protsenko E., Starodubova V., Galkin V.

(Rus)

Rare histological subtypes of bladder cancer in clinical practice: a case series

Paychadze A., Golubeva S., Kamalova M.

(Rus)

Updates in urologic oncology guidelines: prostate cancer: A review

Volkova M., Alekseev B., Nosov D., Nyushko K.

(Rus)

The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study

Chulkova S., Sholokhova E., Poddubnaya I., Stilidi I., Tupitsyn N.

(Rus)

The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial

Volchegorskii I., Vazhenin A., Alekseeva A.

(Rus)

Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Ryazhenov V., Orlov S., Ivakhnenko O.

(Rus)

Immuno-morphological characteristics of bone marrow in patients with ovarian cancer

Kozhonalieva A., Chulkova S., Stilidi I., Artamonova E., Poddubnaya I., Kolbatskaya O., Kupryshina N., Egorova A., Tupitsyn N.

(Rus)

Gastric cancer: Russian clinical guidelines

Besova N., Kalinin A., Nered S., Triakin A., Gamaiunov S., Kozlov N., Stilidi I., Karachun A., Kononets P., Malikhova O., Riabov A., Khomiakov V., Fedenko A., Bolotina L., Falaleeva N., Nevol'skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil'mutdinova I., Eremushkin M., Ivanova G., Kondrat'eva K., Konchugova T., Krutov A., Obukhova O., Semiglazova T., Filonenko E., Khulamkhanova M., Romanov A.

(Rus)

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.

(Rus)

Antiangiogenic therapy for breast cancer with triple negative phenotype

Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.

(Rus)

Can any breast skin thickening be staged as T4?

Amosova V., Petrovskii A., Karpova M., Ponedel’nikova N., Frolova M.

(Rus)

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.

(Rus)

Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy

Kononenko I., Snegovoy A., Grebennikova O., Sel’chuk V., Palchinskaia O.

(Rus)

卷 22, 编号 2 (2020)

Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case

Gorbunova T., Radtsig E., Merkulov O., Bogomil’skii M., Poliakov V.

(Rus)

卷 21, 编号 2 (2019)

The use of regorafenib in colorectal cancer

Sekacheva M., Bagmet N., Guryanova A., Rashi D.

(Rus)

卷 20, 编号 4 (2018)

The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer

Saevets V., Vazhenin A., Chernova L., Shimotkina I., Kurchenkova O., Mukhin A., Taratonov A.

(Rus)

卷 20, 编号 1 (2018)

Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series

Orlova R., Zhukova L., Ganshina I., Yukalchuk D., Ponomarenko D., Beliak N., Gordeeva O., Erdniev S., Minasyan A., Dashkova A., Sopiya E., Sholokhova E., Gurochkin A.

(Rus)

卷 19, 编号 2 (2017)

Clinico-morphological predictors and treatment outcomes in cervical stump cancer

Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.

(Rus)

Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice

Sekacheva M., Bagmet N.

(Rus)

Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study

Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.

(Rus)

卷 17, 编号 3 (2015)

Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)

Fedyanin M.

卷 17, 编号 2 (2015)

Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy

Krivorotko P., Burdaeva O., Nechaeva M., Frolova M., Kopp M., Abrosimova A., Ivanov R.

卷 16, 编号 4 (2014)

Male breast cancer: review of the literature

Nikolaev K., Semiglazov V., Semiglazov V.

卷 16, 编号 2 (2014)

Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment

Skipenko T., Paltseva E., Sekacheva M., Bedganian A.

卷 16, 编号 3 (2014)

Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women

Jackisch C., Llombart-Cussac A.

卷 15, 编号 4 (2013)

Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

Klimenko A., Ivanov S.

卷 15, 编号 4 (2013)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)

Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.

卷 15, 编号 1 (2013)

Diagram of differential diagnostics of stages of ovarian cancer

Antoneeva I., Abakumova T., Gening T., Gening S.

What type of intervention works best to help people with cancer get back to work?(Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

Editorial B.

(Rus)

卷 25, 编号 4 (2023)

Ribociclib + adjuvant hormone therapy in early breast cancer: prevention of recurrence. New opportunities. A review

Ognerubov N.

(Rus)

Opportunities of ICG-fluorescent imaging of lymph nodes during radical cystectomy in patients with bladder cancer: A review

Pavlov V., Urmantsev M., Bakeev M.

(Rus)

Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study

Chulkova S., Sholokhova E., Poddubnaya I., Stilidi I., Burov D., Tupitsyn N.

(Rus)

Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature

Chizh G., Tyutrina Y., Protsenko S., Dzhelialov E., Latipova D.

(Rus)

Recurrent of ovarian cancer with lymph node involvement: surgery or chemotherapy? Retrospective cohort study

Stilidi I., Egenov O., Nered S., Kalinin O., Shevchuk A., Arkhiri P., Suleymanov E., Tyulyandina А.

(Rus)

Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence

Editorial B.

(Rus)

The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021

Editorial B.

(Rus)

Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series

Lyadov V., Moskalenko A., Britskaia N.

(Rus)

Regorafenib in metastatic colorectal cancer: more data for clinical decisions

Petkau V., Karimova A., Akishina Z.

(Rus)

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report

Zhabina A., Moiseenko F., Volkov N., Abduloeva N., Moiseenko V.

(Rus)

Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer

Samaneva N., Vladimirova L., Kolyadina I., Frantsiyants E., Storozhakova A., Bandovkina V., Kalabanova E., Kabanov S., Svetitskaya I., Tishina A., Ezhova M.

(Rus)

Squamous cell breast cancer: description of a rare clinical case

Zikiryakhodjaev A., Khakimova S., Rasskazova E., Saribekian E., Omarova D., Surkova V., Khakimova G.

(Rus)

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Poddubnaya I., Gligorov J., Zhukova L., Kovalenko E., Frolova M.

(Rus)

Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer

Popova A., Fedyanin M., Pokataev I., Tyulyandin S.

(Rus)

卷 22, 编号 2 (2020)

Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer

Statsenko G., Kurakin V., Plokhotenko I.

(Rus)

Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice

Sakaeva D., Ruchkin V., Goncharova O., Abbasova R., Mufazalov F.